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Glycine N-acyltransferase-like 3 is responsible for
long-chain N-acylglycine formation in N18TG2 cells
Kristen A. Jeffries, Daniel R. Dempsey,1 Emma K. Farrell,2 Ryan L. Anderson,
Gabrielle J. Garbade,3 Tatyana S. Gurina, Imran Gruhonjic, Carly A. Gunderson,
and David J. Merkler4
Department of Chemistry, University of South Florida, Tampa, FL 33620
ORCID IDs: 0000-0001-6659-0005 (D.J.M.)

The long-chain fatty acid amides are an emerging family
of bioactive lipids with members that include N-acyl amino
acids, primary fatty acid amides (PFAMs), N-acylarylalkylamides, N-acylethanolamines, and N-monoacylpolyamines.
Fatty acid amides were first identified from biological
sources over 50 years ago with the isolation and identification of N-palmitoylethanolamine from egg yolk in 1957 (1)
and, in 1965, N-palmitoylethanolamine and N-stearoylethanolamine in several tissues from rat and guinea pig
(2). The discovery of N-arachidonoylethanolamine (anandamide) as the endogenous ligand for the mammalian
brain cannabinoid receptor CB1 sparked a dramatic interest in the fatty acid amides (3). Since these early discoveries, a diversity of long-chain fatty acid amides have been
identified in mammals and, more recently, in invertebrates
as well (4–8).
The N-fatty acylglycines, a subclass of the N-fatty acyl
amino acids, are an important class of cell signaling lipids
that are distributed throughout the central nervous system and the rest of the body (6, 7, 9). Identification of
glycine conjugates dates back to the 1820s with the identification of N-benzoylglycine (hippurate) as a mammalian
metabolite (10). N-arachidonoylglycine was the first longchain N-acylglycine identified from a mammalian source
and was determined to have anti-nociceptive and antiinflammatory effects in rat models of pain (11). Since
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Abstract Long-chain fatty acid amides are signaling lipids
found in mammals and other organisms; however, details of
the metabolic pathways for the N-acylglycines and primary
fatty acid amides (PFAMs) have remained elusive. Heavylabeled precursor and subtraction lipidomic experiments in
mouse neuroblastoma N18TG2 cells, a model cell line for
the study of fatty acid amide metabolism, establish the biosynthetic pathways for the N-acylglycines and the PFAMs.
We provide evidence that the N-acylglycines are formed by
a long-chain specific glycine-conjugating enzyme, glycine
N-acyltransferase-like 3 (GLYATL3). siRNA knockdown of
GLYATL3 in the N18TG2 cells resulted in a decrease in the
levels of the N-acylglycines and the PFAMs. This is the first
report of an enzyme responsible for long-chain N-acylglycine
production in cellula. The production of the PFAMs in
N18TG2 cells was reported to occur by the oxidative cleavage of the N-acylglycines, as catalyzed by peptidylglycine amidating monooxygenase (PAM). siRNA knockdown of
PAM resulted in an accumulation of [13C18]N-oleoylglycine
and decreased levels of [13C18]oleamide when the N18TG2
cells were grown in the presence of [13C18]oleic acid.
The addition of [1-13C]palmitate to the N18TG2 cell growth
media led to the production of a family of [1-13C]palmitoylated fatty acid amides, consistent with the biosynthetic pathways detailed herein.—Jeffries, K. A., D. R.
Dempsey, E. K. Farrell, R. L. Anderson, G. J. Garbade, T. S.
Gurina, I. Gruhonjic, C. A. Gunderson, and D. J. Merkler.
Glycine N-acyltransferase-like 3 is responsible for longchain N-acylglycine formation in N18TG2 cells. J. Lipid Res.
2016. 57: 781–790.
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technique to mouse N18TG2 cells because these cells produce
fatty acid amides, including the long-chain N-acylglycines
and PFAMs (12), and express many of the enzymes proposed to function in fatty acid amide metabolism (12, 25,
26). Knockdown of mGLYATL3 in the N18TG2 cells resulted in decreases in the cellular levels of both the longchain N-acylglycines and the PFAMs.
Merkler et al. (12) proposed that the long-chain N-acylglycines are intermediates in the PFAM biosynthetic pathway: fatty acid → fatty acyl-CoA → N-fatty acylglycine →
PFAM (Fig. 1). In this pathway, a long-chain N-acylglycine
is oxidatively cleaved to the corresponding PFAM and
glyoxylate in a reaction catalyzed by peptidylglycine amidating monooxygenase (PAM). PAM knockdown in
the N18TG2 cells resulted in a decrease in the cellular levels
of the PFAMs and an increase in cellular levels of the longchain N-acylglycines; results consistent with the proposed
pathway in Fig. 1. Our research provides key new information regarding the enzyme-catalyzed reactions that occur
in cellula to convert fatty acids into the long-chain N-acylglycines and the PFAMs.

MATERIALS AND METHODS
Materials
N-oleoylglycine, N-palmitoylglycine, N-arachidonoylglycine-d8,
N-oleoylethanolamine, N-palmitoyldopamine, N-oleoyldopamine,
and N-arachidonoyldopamine were from Cayman Chemical Co.
siPORTTM amine transfection reagent and Silencer® Select Predesigned siRNA against mouse (m)PAM and mGLYATL2 were
from Life Technologies. PAM (S-16) primary antibody was from
Santa Cruz Biotechnologies, Inc. Donkey anti-goat secondary
antibody conjugated with horseradish peroxidase was from ICN
Laboratories. mGLYATL3 primary antibody was custom made by
Genscript. Goat anti-rabbit secondary antibody conjugated with

Fig. 1. Proposed pathways for the biosynthesis of the N-acylglycines, PFAMs, and N-acyldopamines in mammalian systems. The novel
enzyme identified in this work, mGLYATL3, is shown in blue. The red carbons represent the metabolic flow of the 13C atom based on data
reported herein.
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2001, other N-acylglycines with varying long-chain N-acyl
groups have been identified in mammals and invertebrates, and have been shown to be important signaling
molecules (4, 5, 7, 12–15). However, the details of longchain N-acylglyine metabolism have remained elusive.
There are two proposed pathways for N-acylgycine biosynthesis: a) sequential oxidation of an N-acylethanolamine
by alcohol dehydrogenase and aldehyde dehydrogenase
(16–19); and b) activation of a fatty acid by an acyl-CoA
synthetase followed by the conjugation with glycine via
a long-chain specific glycine N-acyltransferase (GLYAT)
(Fig. 1) (5, 9, 12, 19, 20).
GLYAT catalyzes the conjugation of short-chain acyl-CoA
thioesters and glycine to produce short-chain N-acylglycines
(C2-C10) (21–23). We proposed that a GLYAT-like (GLYATL)
enzyme would catalyze the formation of long-chain Nacylglycines in a similar reaction in vivo (12, 19). In 2010,
Waluk, Schultz, and Hunt (24) described four human
GLYATs named hGLYAT, hGLYATL1, hGLYATL2, and
hGLYATL3. Interestingly, hGLYATL2 prefers oleoyl-CoA
as a substrate and catalyzes the synthesis of N-oleoylglycine
from oleoyl-CoA and glycine in vitro. A Basic Local Alignment Search Tool (BLAST) search of the hGLYATL orthologs against the mouse genome yielded two GLYATs, mouse
(m)GLYAT and mGLYATL3. Recently, Dempsey et al. (23)
characterized recombinant mGLYAT with glycine serving
as the best amino donor substrate and benzoyl-CoA serving as the best amino acceptor substrate. The formation
of N-acylglycines possessing acyl chains longer than six
carbon atoms was not observed. Therefore, we proposed
that the remaining GLYATL ortholog, mGLYATL3, might
be the enzyme responsible for long-chain N-acylglycine
formation in vivo. To test this hypothesis, we analyzed fatty
acid amide levels before and after knocking down mGLYATL3 expression with siRNA, a technique termed subtraction lipidomics. We applied this subtraction lipidomic
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horseradish peroxidase and -actin loading control antibody
were from Genscript. N,O-bis(trimethylsilyl)trifluoroacetamide
(BSTFA) and silica were from Supelco. Heptadecanoic acid-d33
was from C/D/N Isotopes. Fatty acid-free BSA (BSA), [13C18]oleic
acid, [1-13C]palmitic acid, protease inhibitor cocktail (P8340),
and 6-thioguanine were from Sigma-Aldrich. DMEM and penicillin/
streptomycin were from Mediatech Cellgro. Mouse neuroblastoma N18TG2 cells were from DSMZ (Deutsche Sammlung von Mikrooganism und Zellkuturen GmBH). Polyvinylidene fluoride
membranes were from Millipore. SuperSignal chemiluminescent
horseradish peroxidase substrate was from Pierce. MagicMark XP
molecular weight ladder was from Invitrogen. All other reagents
and cell culture supplies were of the highest quality available
from commercial suppliers.

Methods

Identification and quantification of endogenous long-chain fatty acid
amides in N18TG2 cells by LC/QTOF-MS. Lipids, including the
long-chain fatty acid amides, were extracted from the N18TG2
cells using a previously published extraction method (27, 28).
A solid-phase extraction method described earlier (5, 27) was
subsequently used to further purify the long-chain fatty acid amides from the dried lipid extracts. The fatty acid amide-containing
fractions were combined, dried under N2 at 40°C, and then
stored at 20°C until analyzed in more detail. An Agilent 1260
LC system with a Kinetex™ 2.6 m C18 100 Å (50 × 2.1 mm)
reverse phase column was connected to an Agilent 6540 quadrupole TOF (QTOF) mass spectrometer equipped with a Dual
Agilent Jetstream ESI source in positive ion mode. The LC/
QTOF-MS methods that we used are described in Jeffries et al.
(5). Extracted ion chromatograms were obtained from the
total ion chromatograms for each of the long-chain fatty acid
amides using Agilent MassHunter Qualitative Analysis B.04.00.
The fatty acid amides in each extraction were identified by
comparison to synthetic standards by molecular ion m/z and
retention time. Synthetic standards of the N-acylglycines, Nacyldopamines, and N-acylethanolamines were commercially
available. The PFAMs were synthesized according to Jeffries
et al. (5). Run-to-run variation for all metabolites was less
than ±0.1 min.
Quantification of each identified fatty acid amide was performed by integrating the area under the chromatographic peak
and comparing that value against a standard curve constructed
using the same fatty acid amide. Standard curves were in the linear range of 0.1–10 pmoles on the column (r2 > 0.99). N-arachidonoylglycine-d8, 1 pmole per 10 l injection, was spiked into
each extraction to measure instrument performance and for data
normalization. Solvent and slip additive blanks were run to evaluate background oleamide and palmitamide levels (29). In addition, blank samples were run between standards and extracts to
eliminate memory effects from the HPLC column. Background
levels of these PFAMs were subtracted from analyte levels and
were <10% of the endogenous levels in the N18TG2 cells. The
levels of the N-acyldopamine reported herein represent the sum
total of the amount of the N-acyldopamine and the amount of
the N-acyldopamine quinone. The amounts of endogenous fatty
acid amides in the N18TG2 cells were reported as the average of

RT-PCR of GLYATL3 transcripts. Ambion MicroPoly(A) Purist
kit was used to purify mRNA from N18TG2 cells grown as described above. An Ambion Retroscript kit was used to generate
a cDNA library for RT-PCR experiments. Identification of
mGLYATL3 transcripts was completed by nested RT-PCR. The outer
PCR product was generated with a denaturation step at 95°C for
5 min followed by 30 cycles of 95°C for 30 s, 55°C for 30 s, and
72°C for 1 min. A final extension step was performed at 72°C for
10 min. The nested product was subsequently generated with
the same PCR conditions. The outer primers (sense, CAAATACAAGGGTTGCAAAGTG; antisense, TAACCTTTCCTGCGATGGTC) were designed and synthesized by Eurofins MWG Operon
to amplify a 603 bp product. The amplified product from the
RT-PCR reaction was purified from the outer primers using ultrafiltration with a 100 kDa cut-off filter. The nested primers
(sense, GCGAGAGAGAGAGGCTGAGA; antisense, ATGGAAGCCAGGTTGTCATC) were designed and synthesized by Eurofins
MWG Operon to amplify a 380 bp product. This product was
analyzed by a 1.3% agarose gel and the band was visualized using
0.5 g/ml ethidium bromide under UV light. The positive bands
at 380 bp were cut out of the gel, purified by the Promega Wizard
SV Gel and PCR Clean-up system, and sequenced by Eurofins
MWG Operon.
siRNA knockdown of GLYATL3 in N18TG2 cells. The N18TG2
cells were transfected with anti-mGLYATL3 siRNA using siPORT
amine transfection reagent in order to achieve knockdown of
mGLYATL3. N18TG2 cells were grown to 80% confluency and
then collected by scraping into fresh medium. In each well of a
6-well plate, 2 × 105 cells were transfected with 10 l transfection
reagent and 20 nM siRNA (sense, GGUUGCAAAGUGAAUUAUATT; antisense, UAUAAUUCACUUUGCAACCCT) in growth
medium containing 0% FBS via a “reverse transfection method.”
Cultures were incubated for 5, 8, 12, or 24 h before the cells were
collected by scraping and centrifugation. After washing with PBS,
the cell pellets were stored at 80°C until the long-chain fatty
acid amides were extracted, purified, and analyzed by LC/QTOFMS as described above. Negative controls include: a) incubation
with transfection reagent only or b) transfection reagent with Silencer® Select Negative Control No. 1 (scrambled siRNA). Three
separate independent experiments were performed for each set
of conditions.
siRNA knockdown of PAM and purification of N-oleoylglycine in
N18TG2 cells. The N18TG2 cells were transfected with anti-PAM
siRNA to achieve knockdown of mouse PAM. N18TG2 cells were
grown to 80% confluency in 6-well plates. The medium was removed and replaced with 0.5% FBS medium containing 2.5 mM
[13C18]oleate and 2.5 mM BSA. After 8 h, anti-mPAM siRNA (sense,
GCGGGAAGUUCAUCACUCATT; antisense, UGAGUGAUG
AACUUCCCGCTT) was added to each well in medium with 0%
FBS. After a total incubation time of 56 h, the cells were collected
by scraping and centrifugation. After washing with PBS, cell pellets were stored at 80°C until the labeled fatty acid amides were
extracted. Labeled and unlabeled oleamide was extracted from
the cell pellet and subsequently purified using the methods of
Farrell et al. (28). Labeled and unlabeled N-oleoylglycine was extracted and purified using preparative TLC. Dried lipid extracts
were applied to a prewashed (chloroform:acetone 1:1) 10 cm EMD
analytical normal phase TLC plate. Chloroform:methanol:acetic
acid (95:5:1) was used until the mobile phase reached 5.5 cm

Long-chain N-acylglycine formation in N18TG2 cells
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N18TG2 cell culture. Cells were grown in 225 cm2 culture flasks
in an incubator with a temperature of 37°C and 5% CO2. The
medium was DMEM supplemented with 100 M 6-thioguanine,
10% FBS, 100 IU/ml penicillin, and 1.0 mg/ml streptomycin.
Aliquots of cells were taken for cell counting using a hemocytometer and trypan blue dye.

the determinations along with the standard deviation. For statistical
analyses, the Holm-Šidák method was used to correct for multiple comparisons (30, 31).

Supplemental Material can be found at:
http://www.jlr.org/content/suppl/2016/03/25/jlr.M062042.DC1
.html

[1-13C]palmitate feeding study in N18TG2 cells. N18TG2 cells were
grown to 80% confluency and fresh medium containing 0.5%
FBS, 2.5 mM [1-13C]palmitate, and 2.5 mM BSA was added to the
culture flask. BSA, prepared as described in Farrell et al. (28),
was used as a carrier for [1-13C]palmitate into the N18TG2 cells.
After a 48 h incubation, the medium was removed and the cells
were washed with PBS. Cells were collected by scraping, followed
by centrifugation and washing with PBS. Cell pellets were stored
at 80°C until analyzed by LC/QTOF-MS, as described above.
Similar to the endogenous analysis of the N-acyldopamines,
the levels of [13C]N-acyldopamine and [13C]N-acyldopamine quinone were combined and represented as a total amount for
[13C]acyldopamine.

from the bottom of the plate. The plate was dried and placed
in the second running solvent, hexane:diethyl ether:acetone
(60:40:5), and run until the mobile phase reached 8 cm. After
drying, the final solvent, hexane:diethyl ether (97:3), was run until the mobile phase reached 9.5 cm. An N-oleoylglycine standard
was run alongside the cell extract and visualized using KMnO4
to test for position of the N-acylglycines. The appropriate area
was scraped from the TLC plate into anhydrous isopropanol
and sonicated in a water bath sonicator for 5 min. After initial
sonication, the sample was centrifuged to pellet the silica. The
supernatant liquid was syringe filtered with a 0.22 m filter and
dried under nitrogen at 40–50°C. The silica was subjected to
another round of sonication in isopropanol, centrifugation, and
syringe filtering before adding to the previous supernatant.
Dried samples were trimethylsilylated with 100 l BSTFA. Samples were flushed with dry N2, BSTFA added, flushed briefly
again, and allowed to react at 55–60°C for 1 h before running
on GC-MS. Samples were spiked with an internal standard,
heptadecanoic acid-d33, to monitor instrument performance
and then injected onto a Shimadzu QP-5000 GC-MS using the
conditions described in Farrell et al. (28). Quantification of
analytes was achieved by integration of the area under the chromatographic peak compared with a standard curve. The major
product of oleamide derivitization was oleonitrile, and oleamideTMS was also observed (28). The observed sum of these products represents the level of oleamide in the N18TG2 cell extract,
as determined by standards run with chemically pure oleamide.
The level of the N-oleoylglycine reported herein represents
the sum total of the amount of the observed mono- and di-TMS
derivatives of N-oleoylglycine. Methods were validated by running spiked controls, and extraction efficiency was determined
to be approximately 90% from picomole levels of metabolites
in solution.

RESULTS AND DISCUSSION

Western blotting for RNAi confirmation. Knockdown resulting
from the RNAi experiments was monitored via Western blotting.
Ten percent SDS-PAGE was run and, subsequently, electroblotted to a polyvinylidene fluoride membrane. The membranes were
blocked with 5% nonfat dry milk, incubated with the respective
primary antibody, and treated with a secondary antibody conjugated
to horseradish peroxidase. Visualization of bands was achieved with
the SuperSignal chemiluminescent system on radiographic film.
-Actin antibody was used as a loading control.

TABLE 1. Identification of endogenous long-chain fatty acid amides in N18TG2 cell extracts by LC/QTOF-MS
Standard
Fatty Acid Amide

+
[M+H] (m/z)

[M+H]+ (m/z)

Retention Time
(minutes)

314.2966
340.2929

5.892
5.995

314.2487
340.2895

5.838
5.963

326.3079

5.982

326.2736

5.996

256.2619
254.2487
282.2869
280.2646

6.023
5.768
6.177
5.902

256.2637
254.2282
282.2578
280.2378

6.035
5.755
6.129
5.838

392.3163
390.2958
418.3367
416.3412
440.3198
438.3832

6.053
6.148
6.132
6.256
5.885
5.948

392.2726
390.2714
418.2215
416.2446
440.2375
438.3310

6.054
6.118
6.121
6.245
5.896
5.946

N-acylglycines
N-palmitoylglycine
N-oleoylglycine
N-acylethanolamines
N-oleoylethanolamine
PFAMs
Palmitamide
Palmitoleamide
Oleamide
Linoleamide
N-acyldopamines
N-palmitoyldopamine
N-palmitoyldopamine quinone
N-oleoyldopamine
N-oleoyldopamine quinone
N-arachidonoyldopamine
N-arachidonoyldopamine quinone
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Identification and quantification of endogenous long-chain
fatty acid amides in N18TG2 cells by LC/QTOF-MS
A panel of long-chain fatty acid amides was identified
in N18TG2 cell extracts by comparison of molecular ion
m/z values and chromatographic retention times against
synthetic standards via LC/QTOF-MS analysis (Table 1).
The chromatographic retention time and mass spectrum of endogenous palmitamide identified in an N18TG2
cell extract matched those of a palmitamide synthetic
standard (Fig. 2). These data are representative of the
data collected for each endogenous fatty acid amide
identified in N18TG2 cells. Tandem MS analyses further
validated the identification of these metabolites (supplementary Table 1). The identification of the PFAMs and
N-acylglycines is consistent with the previous identification of these metabolites in N18TG2 cell extracts, as well
as their proposed role as brain signaling lipids (12, 28,
32, 33). This is the first report of the identification of
N-palmitoyldopamine, N-oleoyldopamine, and N-arachidonoyldopamine in N18TG2 cells. A previous report identified N-arachidonoylethanolamine in the N18TG2 cells
at levels below our limit of detection (32). Endogenous
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Fig. 2. Identification of palmitamide in an N18TG2 cell extract by LC/QTOF-MS. The extracted ion chromatograms peak and mass spectrum of a synthetic standard, palmitamide (A), matched those of endogenous palmitamide identified in the N18TG2 extract (B). These data
are representative of the data collected for each long-chain fatty acid amide identified in N18TG2 extract herein.

amounts of the identified long-chain fatty acid amides
were obtained by integrating the area under the chromatographic peak and comparing the integrated value
against a standard curve prepared using the respective
synthetic standard (supplementary Table 2). Known to
be potent cell-signaling lipids, these long-chain fatty acid
amides are found at cellular levels on the order of picomoles per 107 cells. Palmitamide was the most abundant
fatty acid amide with an endogenous amount of 1,300 ±
98 pmoles per 107 cells, while palmitoleamide was the
least abundant.

N18TG2 cells express GLYATL3 transcripts
Nested PCR primers were designed to amplify a 380 bp
mGLYATL3 product from a cDNA library constructed
from the mRNA extracted from an N18TG2 cell pellet.
After the first round of PCR, the product was filtered
and then used as the template in a second reaction
with nested primers. Nested primers were necessary
due to the low abundance of mGLYATL3 transcripts in
N18TG2 cells. The 380 bp product isolated from the agarose electrophoresis gel was positively identified to be
mGLYATL3 by DNA sequencing (supplementary Fig. 1).
Long-chain N-acylglycine formation in N18TG2 cells
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These data indicate that N18TG2 cells express mGLYATL3
transcripts.

Fig. 3. Western blot analysis of mGLYATL3 RNAi in
N18TG2 cells. A: All lanes contain 22 g of N18TG2 cell
lysate and were incubated with anti-mGLYATL3
siRNA for the respective number of hours. B: RNAi
controls in N18TG2 cells. All lanes contain 20 g of
N18TG2 cell lysate and were incubated with no siRNA
or scrambled siRNA for the respective number of
hours. -Actin was used as a loading control.
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siRNA knockdown of GLYATL3 results in decreased
levels of N-acylglycines and PFAMs
Transfection of siRNA against mGLYATL3 into N18TG2
cells resulted in the knockdown of mGLYATL3 expression for 12 h (Fig. 3). While mGLYATL3 expression levels
decreased 103 ± 13% during knockdown, -actin levels
only changed 12 ± 7% (Fig. 3). After 24 h, the expression
of mGLYATL3 returned to normal levels, which limited
our ability to do a heavy-labeled precursor study during
mGLYATL3 knockdown. The mGLYATL3 primary antibody was specific for recombinant maltose binding protein-tagged mGLYATL3, but not recombinant mGLYAT
(23) (supplementary Fig. 2). After 8 and 24 h, the transfected cells were collected and the long-chain fatty acid
amides extracted, purified, and analyzed by LC/QTOFMS. A panel of identified fatty acid amides were quantified
and compared with endogenous levels (supplementary
Table 2). At the 8 h time point, mGLYATL3 expression was
silenced and there were significant changes in N-acylglycine
and PFAM levels. N-oleoylglycine levels decreased 99.4%
relative to the untransfected control, while oleamide levels
decreased 93.6%. Similarly, N-palmitoylglycine levels decreased 90.4% relative to the untransfected control, while
palmitamide levels decreased 86.9%. These data (Fig. 4)
indicate that: a) mGLYATL3 has a major role in N-acylglycine
formation in these cells; and b) that the N-acylglycines are
precursors for PFAMs. Both are consistent with the biosynthetic pathways for the N-acylglycines and PFAMs that we
have proposed (Fig. 1). The differences in the percentage
changes between oleoylated or palmitoylated amides are

unclear and there are many factors contributing to these
differences. One possibility could be differences between
the rates of hydrolysis of N-acylglycines relative to PFAMs
by fatty acid amide hydrolase (FAAH) (34). Other than
changing the cellular levels of the N-acylglycines and
PFAMs, the knockdown of mGLYATL3 expression resulted
in no change in N-oleoylethanolamine levels and an increase in N-acyldopamine levels. The increases in N-acyldopamine levels were unexpected, but could be due to an
increase in acyl-CoAs available for conjugation to dopamine
by an unidentified arylalkylamine N-acyltransferase-like
(AANATL) enzyme. In Drosophila, AANATL2 catalyzes
the formation of long-chain N-acyldopamines in vitro (35,
36) and we propose that a mammalian AANATL2 ortholog could be responsible for N-acyldopamine formation in
the N18TG2 cells.
Controls for this siRNA experiment indicate that overall protein expression was unaffected by the knockdown
of mGLYATL3, as -actin expression was unchanged
(Fig. 3). Average cell viability during knockdown was
80% relative to the experiment with cells transfected with
scrambled siRNA. At the 24 h time point, average cell viability was 88% when the cells were returning to normal
metabolism. Negative controls included incubation with
transfection reagent only or transfection reagent with
scrambled siRNA. Long-chain fatty acid amide levels
were unchanged in these control experiments (Table 2).
When the transient knockdown of mGLYATL3 is no longer present in the cell culture (at the 24 h time point),
N-acylglycine and PFAM levels increase. This further
validates the role of mGLYATL3 in the production of
the N-acylglycines as intermediates in the biosynthesis of
the PFAMs.
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siRNA knockdown of PAM results in an accumulation of
N-oleoylglycine and a decrease in oleamide levels
Transfection of siRNA against PAM into N18TG2 cells
resulted in the knockdown of PAM expression for 48 h
(Fig. 5). The average viability after 48 h was 56% relative to
untransfected cells. Because a large number of peptide
hormones are -amidated for biological activation (37), a
decrease in cell viability was expected upon the knockdown
of PAM. After a total of 56 h of incubation with anti-PAM
siRNA and 48 h with [13C18]oleate, the cells were collected and the amounts of labeled and unlabeled N-oleoylglycine and oleamide were analyzed and quantified. In a
previous study, the incubation of N18TG2 cells with a
PAM inhibitor, trans-4-phenyl-3-butenoic acid, resulted in
the accumulation of N-oleoylglycine (12). Consistent with
these earlier results, decreased expression of PAM resulted in the accumulation of N-oleoylglycine and a decrease in oleamide levels relative to endogenous amounts

(Fig. 6). These data provide additional evidence that
PAM is involved in the conversion of N-acylglycines to
PFAMs in cellula.
N18TG2 cells incubated with [1-13C]palmitate lead to a
13
family of [1- C]palmitoylated fatty acid amides
13
The N18TG2 cells were incubated with [1- C]palmitate
in order to investigate metabolic flux after being exposed
to a heavy-labeled precursor. After a 48 h incubation with
[1-13C]palmitate using BSA as a carrier, the lipids were
extracted from the cells to analyze for fatty acid amides
that contained the 13C-N-palmitoyl chain as well as the other
unlabeled metabolites. [13C]N-palmitoylglycine, [13C]Npalmitamide, and [13C]N-palmitoyldopamine were identified in cell extracts, showing that these metabolites are
synthesized from the exogenous [1-13C]palmitate (Table 3).
The total palmitamide (13C-labeled and unlabeled) in the
N18TG2 cells that were incubated with [1-13C]palmitate was
Long-chain N-acylglycine formation in N18TG2 cells
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Fig. 4. Subtraction lipidomics: quantification of endogenous long-chain fatty acid amides in N18TG2 cell extracts by LC/QTOF-MS with
mGLYATL3 RNAi. Endogenous amounts of the N-acylglycines along with the amounts with mGLYATL3 RNAi are in (A). Endogenous
amounts of the long-chain PFAMs along with the amounts with mGLYATL3 RNAi are in (B). Error bars represent ±standard deviation,
n = 3. Statistically significant changes (P < 0.05) are marked with an asterisk (*).
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TABLE 2. RNAi controls: quantification of long-chain fatty acid amides in N18TG2 cell extracts by LC/QTOF-MS
a
7
Amount (picomoles per 10 cells)

Fatty Acid Amide

N-acylglycines
N-palmitoylglycine
N-oleoylglycine
N-acylethanolamines
N-oleoylethanolamine
PFAMs
Palmitamide
Palmitoleamide
Oleamide
Linoleamide
N-acyldopamines
N-palmitoyldopamine
N-oleoyldopamine
N-arachidonoyldopamine
a
b
c

(+) Scrambled siRNA
(+) Transfection
b
Reagent

(+) Scrambled siRNA
(+) Transfection
c
Reagent

() Scrambled siRNA
() Transfection
c
Reagent

90 ± 18
530 ± 250

69 ± 18
870 ± 320

92 ± 6.0
2000 ± 480

120 ± 72
450 ± 240

26 ± 16

43 ± 34

16 ± 15

2.8 ± 2.0

510 ± 100
12 ± 3.4
1300 ± 150
280 ± 32

640 ± 400
19 ± 14
1,200 ± 310
230 ± 35

500 ± 190
29 ± 6.6
20 ± 7.9

290 ± 310
24 ± 8.2
17 ± 3.9

620 ± 39
24 ± 1.8
1,200 ± 1,100
410 ± 220

320 ± 170
10 ± 5.6
1,200 ± 320
320 ± 61

930 ± 360
83 ± 33
31 ± 12

570 ± 62
65 ± 48
8.8 ± 0.5

No statistically significant changes between any two groups were reported (P > 0.05).
Eight hour incubation.
Twenty-four hour incubation.

CONCLUSIONS
mGLYATL3 catalyzes the formation of long-chain Nacylglycines in cellula. Subtraction lipidomic data observed
a decrease in N-acylglycine and PFAM levels in N18TG2
cells after the siRNA-mediated knockdown of mGLYATL3.
These data support the proposed biosynthetic pathway of
activation of a fatty acid by acyl-CoA synthetase followed by

Fig. 5. Western blot analysis of PAM RNAi in N18TG2 cells. N18TG2
cells were exposed to anti-PAM siRNA or a scrambled siRNA for
the respective number of hours.

Journal of Lipid Research Volume 57, 2016

the conjugation of the resulting acyl-CoA with glycine. It
is known that long-chain fatty acid amides can be produced by more than one route; there is evidence for their
biosynthesis by the sequential oxidation of N-acylethanolamines (16–18, 20). There is evidence that this alternative
pathway does take place in the N18TG2 cells (28). The subtraction lipidomic data herein suggests that the glycinedependent route is the predominant route for long-chain
N-acylglycine synthesis in these cells because N-acylgycine
levels were not rescued by an alternative biosynthetic pathway during mGLYATL3 knockdown. This is the first report
of an enzyme responsible for the biosynthesis of longchain N-acylglycines in cellula. In vitro data obtained using
purified recombinant GST-tagged mGLYATL3 shows the
production of N-oleoylglycine from oleoyl-CoA and glycine
providing support for our in cellula results (supplementary Table 3). Furthermore, Waluk, Schultz, and Hunt
(24) previously described a human enzyme, hGLYATL2,
that catalyzes the conjugation of long-chain acyl-CoA
thioesters to glycine in vitro. Interestingly, our BLAST
searches did not identify orthologs of hGLYATL2 in organisms known to produce long-chain N-acylglycines, such
as the mouse and the rabbit. However, these species did
have putative orthologs of mGLYATL3. A similar strategy
employed by Saghatelian and Cravatt [discovery metabolic
profiling, see (38)] led to the identification of N-acyltaurines as substrates for FAAH, despite the relatively low
kcat/KM values obtained in vitro for the FAAH-catalyzed
hydrolysis for the N-acyltaurines. As these authors point
out (39), in vitro substrate specificity data obtained using
a purified enzyme may not perfectly predict in vivo substrates for the same enzyme because proteins often function as partners in multi-protein complexes and networks
and may be regulated in ways not fully captured in in vitro
experiments. A subsequent decrease in PFAM levels with
the knockdown of mGLYATL3 gives support to the proposed role for the N-acylglycines as intermediates in the
biosynthesis of the long-chain PFAMs. These data are further validated by the siRNA-mediated knockdown of the

Downloaded from www.jlr.org at Univ Of South Florida, on June 8, 2018

990 ± 480 pmoles per 107 cells, consistent with the endogenous amount of palmitamide reported herein, 1,300 ±
98 pmoles per 107 cells. A similar trend was also observed
for N-palmitoyldopamine. A low percentage, 0.1%, of
the incubated [1-13C]palmitate was converted to labeled
N-palmitoylglycine, palmitamide, or N-palmitoyldopamine
by N18TG2 cells.

788

() Scrambled siRNA
(+) Transfection
c
Reagent
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N-acylglycine amidating enzyme, PAM. Knockdown of
PAM resulted in a decrease in oleamide levels and an increase in N-oleoylglycine levels. Lastly, the results of our
heavy-labeled precursor feeding study were consistent with

the following biosynthetic pathway: fatty acid → fatty acylCoA → N-fatty acylglycine → PFAM (Fig. 1).
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